In the News - FDA
What's New with FDA?
The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) is hosting a virtual […]
Judge Jesus Bernal ruled in federal court in California’s Central District against the FDA’s argument that a group of stem […]
While aging affects most living organisms, the hydrozoan Turritopsis dohrniiis the only species able to rejuvenate repeatedly after sexual reproduction, […]
The FDA granted fast track designation to ALLO-316, an investigational chimeric antigen receptor T-cell therapy, for the treatment of adults […]
Collection and analysis of real-world data (RWD) continue to gain traction in the biomedical community, accompanied by a growing understanding […]
As medicines development continues towards a globalized approach, both the pharmaceutical industry and regulatory agencies increasingly seek opportunities to proactively […]
The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) is hosting a public […]
